MREO Mereo Biopharma Group PLC
Fundamentals / CIK 0001719714 / USDMereo Biopharma Group PLC reported $500K in revenue and a net loss of $26.94M for the fiscal year ended December 31, 2025, with a -6080.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MREO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$500K Dec 31, 2025
-
Operating Income FY 2025-$30.40M -6080.8% margin
-
Net Income FY 2025-$26.94M -5387.6% net margin
-
Diluted EPS FY 2025-$0.03 Split-adjusted
-
Free Cash Flow FY 2025-$22.09M -4417.6% FCF margin
-
Cash & ST Investments Sep 30, 2026$26.10M Total debt: $577K
Annual revenue and net income
4 fiscal years (2022 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Revenue | $500K | $0 | $10.00M | $0 |
| Research & Development | $17.77M | $20.93M | $17.42M | $29.46M |
| Operating Income | -$40.11M | -$47.36M | -$28.42M | -$54.43M |
| EBITDA | -$39.48M | -$46.78M | -$27.85M | -$54.24M |
| Interest Income | $2.17M | $3.04M | $2.13M | $840K |
| Interest Expense | $255K | $1.37M | $2.88M | $4.17M |
| Income Before Tax | -$41.88M | -$43.25M | -$30.00M | -$42.94M |
| Income Tax Expense | $0 | $0 | -$532K | -$718K |
| Net Income | -$41.88M | -$43.25M | -$29.47M | -$42.22M |
| Basic EPS | -$0.05 | -$0.06 | -$0.04 | -$0.07 |
| Diluted EPS | -$0.05 | -$0.06 | -$0.04 | -$0.07 |
| Basic Shares Outstanding | 797.1M | 739.6M | 659.5M | 603.2M |
| Diluted Shares Outstanding | 797.1M | 739.6M | 659.5M | 603.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $800K | $0 | -- | -- | $0 | $500K | -- | $0 |
| Research & Development | $2.09M | $1.81M | $4.75M | $4.19M | $4.27M | $5.37M | $3.93M | $8.82M |
| Operating Income | -$6.22M | -$7.03M | -$8.77M | -$8.39M | -$10.02M | -$10.50M | -$11.20M | -$15.28M |
| EBITDA | -$6.06M | -$6.87M | -$8.60M | -$7.93M | -$10.16M | -$10.34M | -$11.06M | -$15.13M |
| Interest Income | $241K | $278K | $327K | $421K | $504K | $589K | $659K | $881K |
| Interest Expense | $10K | $16K | $20K | $23K | $28K | $24K | $180K | $375K |
| Income Before Tax | -$5.86M | -$7.00M | -$6.72M | -$7.35M | -$7.02M | -$14.62M | -$12.89M | -$7.05M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$5.86M | -$7.00M | -$6.72M | -$7.35M | -$7.02M | -$14.62M | -$12.89M | -$7.05M |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -- | -$0.01 | -$0.02 | -$0.02 | -- |
| Diluted EPS | -$0.01 | -$0.01 | -$0.01 | -- | -$0.01 | -$0.02 | -$0.02 | -- |
| Basic Shares Outstanding | 804.5M | 803.6M | 801.8M | -- | 799.9M | 799.4M | 784.3M | -- |
| Diluted Shares Outstanding | 804.5M | 803.6M | 801.8M | -- | 799.9M | 799.4M | 784.3M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $40.99M | $69.80M | $57.42M | $68.18M |
| Cash & Short-Term Investments | $40.99M | $69.80M | $57.42M | $68.18M |
| Total Current Assets | $45.02M | $74.76M | $63.76M | $75.20M |
| Property, Plant & Equipment, Net | $137K | $257K | $405K | $551K |
| Intangible Assets | $516K | $643K | $1.09M | $0 |
| Total Non-Current Assets | $897K | $1.63M | $2.74M | $2.22M |
| Total Assets | $45.92M | $76.39M | $66.50M | $77.41M |
| Accounts Payable | $1.33M | $2.44M | $2.35M | $3.49M |
| Deferred Revenue (Current) | $0 | -- | -- | -- |
| Other Current Liabilities | $741K | $1.09M | $1.02M | $1.07M |
| Total Current Liabilities | $4.30M | $13.85M | $9.49M | $24.38M |
| Other Non-Current Liabilities | $661K | $565K | $764K | $0 |
| Total Non-Current Liabilities | $699K | $1.57M | $6.48M | $1.64M |
| Total Liabilities | $5.00M | $15.42M | $15.96M | $26.01M |
| Total Debt (incl. Leases) | $202K | $894K | $1.56M | $2.04M |
| Common Stock | $3.13M | $3.06M | $2.77M | $2.48M |
| Retained Earnings | -$501.0M | -$462.9M | -$419.6M | -$404.6M |
| Accumulated Other Comp. Income | -$10.82M | -$18.85M | -$17.48M | -$21.69M |
| Total Stockholders' Equity | $40.92M | $60.97M | $50.54M | $51.40M |
| Total Equity | $40.92M | $60.97M | $50.54M | $51.40M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $26.10M | $30.12M | $30.10M | $40.99M | $48.70M | $56.12M | $62.48M | $69.80M |
| Cash & Short-Term Investments | $26.10M | $30.12M | $30.10M | $40.99M | $48.70M | $56.12M | $62.48M | $69.80M |
| Total Current Assets | $28.67M | $33.40M | $40.03M | $45.02M | $52.41M | $61.42M | $66.90M | $74.76M |
| Property, Plant & Equipment, Net | $24K | $54K | $91K | $137K | $174K | $218K | $247K | $257K |
| Intangible Assets | $129K | $256K | $381K | $516K | $643K | $470K | $554K | $643K |
| Total Non-Current Assets | $911K | $1.31M | $580K | $897K | $1.20M | $1.21M | $1.42M | $1.63M |
| Total Assets | $29.58M | $34.71M | $40.61M | $45.92M | $53.60M | $62.63M | $68.32M | $76.39M |
| Accounts Payable | $1.00M | $1.12M | $3.23M | $1.33M | $879K | $1.14M | $2.92M | $2.44M |
| Deferred Revenue (Current) | $200K | -- | -- | $0 | -- | -- | -- | -- |
| Other Current Liabilities | $888K | $1.07M | $905K | $741K | $622K | $777K | $894K | $1.09M |
| Total Current Liabilities | $5.49M | $5.68M | $6.18M | $4.30M | $6.02M | $7.56M | $7.50M | $13.85M |
| Other Non-Current Liabilities | $370K | $370K | $362K | $661K | $652K | $352K | $325K | $565K |
| Total Non-Current Liabilities | $378K | $385K | $383K | $699K | $988K | $897K | $744K | $1.57M |
| Total Liabilities | $5.87M | $6.06M | $6.56M | $5.00M | $7.00M | $8.45M | $8.24M | $15.42M |
| Total Debt (incl. Leases) | $577K | $1.03M | -- | $202K | $397K | $601K | $747K | $894K |
| Common Stock | $3.15M | $3.15M | $3.15M | $3.13M | $3.13M | $3.13M | $3.13M | $3.06M |
| Retained Earnings | -$520.4M | -$514.5M | -$507.5M | -$501.0M | -$493.7M | -$486.6M | -$472.0M | -$462.9M |
| Accumulated Other Comp. Income | -$12.27M | -$12.29M | -$12.57M | -$10.82M | -$10.91M | -$8.64M | -$15.29M | -$18.85M |
| Total Stockholders' Equity | $23.71M | $28.65M | $34.05M | $40.92M | $46.60M | $54.18M | $60.08M | $60.97M |
| Total Equity | $23.71M | $28.65M | $34.05M | $40.92M | $46.60M | $54.18M | $60.08M | $60.97M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Net Income | -$41.88M | -$43.25M | -$29.47M | -$42.22M |
| Depreciation & Amortization | $622K | $581K | $566K | $181K |
| Stock-Based Compensation | $7.60M | $7.39M | $4.92M | $4.77M |
| Change in Payables | -$1.38M | $146K | -$1.26M | $617K |
| Operating Cash Flow | -$30.97M | -$32.83M | -$21.13M | -$48.82M |
| Capital Expenditure | -$20K | $0 | $0 | -$13K |
| Free Cash Flow | -$30.99M | -$32.83M | -$21.13M | -$48.83M |
| Investing Cash Flow | -$20K | -$699K | -$419K | $1.99M |
| Common Stock Issued | $39K | $47.00M | $11.61M | $0 |
| Financing Cash Flow | $327K | $46.15M | $7.97M | $200K |
| Net Change in Cash | -$30.66M | $12.38M | -$10.76M | -$46.63M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$5.86M | -$7.00M | -$6.72M | -$7.35M | -$7.02M | -$14.62M | -$12.89M | -$7.05M |
| Depreciation & Amortization | $159K | $165K | $171K | $460K | -$144K | $162K | $144K | $148K |
| Stock-Based Compensation | $909K | $1.32M | $1.60M | $1.54M | $1.71M | $2.06M | $2.28M | $1.51M |
| Change in Payables | -$118K | -$2.14M | $1.96M | $447K | -$236K | -$1.95M | $362K | $843K |
| Operating Cash Flow | -$4.05M | -$6.04M | -$4.31M | -$7.68M | -$7.31M | -$7.65M | -$8.33M | -$9.42M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | -$20K | $0 |
| Free Cash Flow | -$4.05M | -$6.04M | -$4.31M | -$7.68M | -$7.31M | -$7.65M | -$8.35M | -$9.42M |
| Investing Cash Flow | $0 | $0 | -$300K | $0 | $300K | $0 | -$320K | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $39K | $0 | -$134K | $422K | -$40K |
| Net Change in Cash | -$4.05M | -$6.04M | -$4.61M | -$7.64M | -$7.01M | -$7.79M | -$8.23M | -$9.46M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Operating Margin | -8021.4% | -- | -284.2% | -- |
| Net Profit Margin | -8375.6% | -- | -294.7% | -- |
| Return on Equity (ROE) | -102.4% | -70.9% | -58.3% | -82.1% |
| Return on Assets (ROA) | -91.2% | -56.6% | -44.3% | -54.5% |
| Current Ratio | 10.46x | 5.40x | 6.72x | 3.09x |
| Quick Ratio | 9.53x | 5.04x | 6.05x | 2.80x |
| Debt to Equity | 0.00x | 0.01x | 0.03x | 0.04x |
| Revenue Growth (YoY) | -- | -100.0% | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -113.6% | -98.1% | -104.9% | -102.4% | -89.2% | -91.5% | -78.5% | -70.9% |
| Return on Assets (ROA) | -91.1% | -80.9% | -87.9% | -91.2% | -77.6% | -79.1% | -69.1% | -56.6% |
| Current Ratio | 5.22x | 5.88x | 6.48x | 10.46x | 8.71x | 8.13x | 8.92x | 5.40x |
| Quick Ratio | 4.75x | 5.31x | 4.87x | 9.53x | 8.09x | 7.43x | 8.33x | 5.04x |
| Debt to Equity | 0.02x | 0.04x | -- | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x |
| Revenue Growth (YoY) | -- | -100.0% | -- | -- | -- | -- | -- | -100.0% |